Next Tuesday, most of the attention will go to Nebraska‘s fascinating, late-breaking GOP Senate primary, which doubles as conservative outside groups’ best chance to snare a Senate seat in 2014. Keep an eye on WV-02, too, one of the places where Senate Conservatives Fund and others are trying to build a farm team to give themselves more opportunities in the future.
— Especially with state Mississippi state Sen. Chris McDaniel (R) suffering from revelations of old radio comments, Nebraska’s Ben Sasse (R) is the greatest remaining hope for groups like SCF after setbacks across the map this year. With banker Sid Dinsdale (R) making a late self-funded charge after frontrunners Sasse and Shane Osborn (R) beat each other up, the stakes are very high for a few outside groups looking for wins next Tuesday.
— Meanwhile, in WV-02, SCF and friends have focused on the state’s open House district after failing to prevent its current occupant, Rep. Shelley Moore Capito (R), from breezing to the party’s Senate nomination. Groups like the SCF, the Club for Growth and other gnashed their teeth over Capito’s Senate run in late 2012—but they couldn’t derail it. By supporting Alex Mooney (R) in WV-02 and House candidates in a few other states this year, SCF and other endorsers are looking to seed the House with future Senate contenders to prevent the scenario from repeating.
— Mooney has outspent the field to put himself in position, but that strength highlights something else: The former Maryland GOP chair, who was a state senator there and considered running for MD-06 in 2012, is getting almost completely funded from out of state. He brought in less than $10,000 in itemized donations from West Virginia in 2013, and the pace hasn’t picked up much: His pre-primary FEC report shows just three West Virginia individual donors.
It’s not that there’s no local money to be had: In neighboring WV-03, Evan Jenkins (R) has raised well over a quarter-million dollars in itemized donations from West Virginians. There’s simply a lot of outside interest in what happens to WV-02 this year.
- 1 The Story of 2016: Republicans Feeling “Betrayed” by Their Leaders
- 2 The 14 House Primaries to Watch Tuesday
- 3 After Trump, GOP Foreign Policy Faces an Uncertain Future
- 4 Climate Stances Put Pressure on Major Trade Groups
- 5 Smart Ideas: Oil Pipelines vs. Oil Trains, and the Next Generation of Biological Threats
What We're Following See More »
Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.